Product Information

AUROVELA 1 MG-20 MCG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1672 per EA under NDC 65862093988. Its NADAC has been published 386 times since Jul 3, 2019.

FDA first approved this application on Jun 16, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AUROVELA 1 MG-20 MCG TABLET

Norethindrone Acetate and Ethinyl Estradiol
$0.1672per EA

Strength

20; 1 ug/1; mg/1

NDC

65862093988

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207506

FDA Approved

6/16/2017

TE Code

AB

On Market Since

6/16/2017

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Progesterone Congeners
Progestin

Price Statistics

The NADAC for AUROVELA 1 MG-20 MCG TABLET has been published 386 times since Jul 3, 2019, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1672 per EA
All-time high$0.4141 (Aug 14, 2019)
All-time low$0.1619 (Nov 20, 2024)
52-week high$0.1842
52-week low$0.1652
Median price$0.2611
Average price$0.2661
Largest weekly change+34.5% (Aug 21, 2024)
Weeks tracked386
Tracking sinceJul 3, 2019

Price History

1W

-5.0%

1M

-7.7%

3M

-9.2%

6M

-1.4%

1Y

-1.8%

3Y

-24.0%

5Y

-49.1%

All

-57.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AUROVELA 1 MG-20 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AUROVELA 1 MG-20 MCG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1672 per EA (NDC 65862093988), effective Nov 18, 2026.

How has the price of AUROVELA 1 MG-20 MCG TABLET changed over time?

Over the history we have for it, the NADAC for AUROVELA 1 MG-20 MCG TABLET has declined 57.5%. It has been tracked across 386 weekly CMS publications since Jul 3, 2019.

What are the highest and lowest recorded NADAC prices for AUROVELA 1 MG-20 MCG TABLET?

Since Jul 3, 2019, the NADAC for AUROVELA 1 MG-20 MCG TABLET has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.4141 (Aug 14, 2019), with a median of $0.2611 per EA.

Are there cheaper alternatives to AUROVELA 1 MG-20 MCG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AUROVELA 1 MG-20 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures AUROVELA 1 MG-20 MCG TABLET?

AUROVELA 1 MG-20 MCG TABLET (NDC 65862093988) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.